<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5283600 Figure_1-B</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, ITC experiment shows the CBS-pair domain of CNNM3 binds PRL2 with a nanomolar Kd and one-to-one stoichiometry.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_1-D</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, Structure of CBS-pair domain of CNNM2 (PDB 4IY0) with the residues DPFYE indicated.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_1-F</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F, ITC data of CBS-pair domain mutants binding to PRL2 identifies aspartic acid 426 as essential for binding.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_1-G</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G, Kinetics of hydrolysis of a synthetic substrate by PRL2 shows burst kinetics. Addition of the wild-type CBS-pair domain but not the D426A mutant inhibits phosphatase activity.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_2-A</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, Treatment of PRL2 with a synthetic substrate leads to complete phosphorylation of the catalytic residue, cysteine 101. Recombinant PRL2 was treated with 3-O-methylfluorescein phosphate (OMFP) and analyzed by SDS-PAGE with the Phos-tag reagent. Phosphocysteine is hydrolyzed by boiling.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_2-B</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, Detection of phosphorylated by electrospray mass spectrometry. OMFP-treatment increased the mass of the intact protein by 79.99 amu but had no effect on the C101A mutant.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_2-C</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C, 31P NMR spectrum of the thioPO3 signal from phosphocysteine in PRL2. The broad peak is TCEP in the buffer.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_2-D</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, Cysteine phosphorylated PRL2 does not bind to CNNM3. Recombinant PRL2 was phosphorylated by treatment with OMFP and subjected to pull-down by the CBS-pair domain of CNNM3 as a GST fusion. Only unphosphorylated PRL2 was observed in the pull-down lanes while phosphorylated PRL2 was in the flow-through lanes.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_2-E</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E, ITC measurement of the affinity of PRL2 for the CNNM3 GST-CBS-pair domain. Phosphorylation by OMFP completely blocked binding while oxidization of PRL2 by diamide decreased the affinity 200-fold.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_2-F</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F, The cysteine residues in the PRL2 active site are not required for binding the CNNM3 CBS-pair domain.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_3-A</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, Mutations in the CBS-pair loop of CNNM4 prevent binding to PRL3. Lysates of COS7 cells transfected with the indicated constructs were subjected to immunoprecipitation (IP) and immunoblotting (IB) with the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_3-B</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B &amp; C, Wild-type CNNM4-dependent magnesium efflux is inhibited by co-transfection by PRL3 but the efflux by the CNNM4 D485A mutant, which is unable to bind PRL3, is resistant to inhibition. HEK293 cells transfected with the indicated constructs were loaded with Magnesium Green and Mg2+ removed from the medium at the indicated time point (arrowhead). The means of relative fluorescence intensities of 10 cells are graphed as a function of time in panel B and the mean and s.e.m. at 5 min plotted in panel C. P-values were calculated using one way ANOVA followed by Bonferroni's multiple comparison test. n.s., not significant.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_3-C</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>B &amp; C, Wild-type CNNM4-dependent magnesium efflux is inhibited by co-transfection by PRL3 but the efflux by the CNNM4 D485A mutant, which is unable to bind PRL3, is resistant to inhibition. HEK293 cells transfected with the indicated constructs were loaded with Magnesium Green and Mg2+ removed from the medium at the indicated time point (arrowhead). The means of relative fluorescence intensities of 10 cells are graphed as a function of time in panel B and the mean and s.e.m. at 5 min plotted in panel C. P-values were calculated using one way ANOVA followed by Bonferroni's multiple comparison test. n.s., not significant.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_4-A</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, The CBS-pair domain (yellow) forms a dimer and binds two molecules of PRL2 via an extended loop. The positions of the PRL2 C-terminal CAAX prenylation motif [42] and CNNM3 N-terminus suggest that the membrane would sit above the complex.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_4-B</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, Contacts between the CNNM3 CBS2 loop and the PRL2 active site.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_4-C</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C, Stereoview of the 2FO-FC omit map of the PRL2 binding loop of CNNM3 contoured at 1 .</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_4-D</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, Detail of complex with reduced PRL2, showing how CNNM3 Asp426 inserts into the pocket adjacent to the catalytic cysteine Cys101.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_4-E</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E, Model of phosphocysteine preventing CNNM binding. Crystal structure of PRL1 with a bound sulfate shows phosphocysteine would prevent Asp426 binding. Residues are numbered according to the PRL1 structure (PDB 1XM2).</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_5-A</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, PRLs expressed in HEK293 cells are intrinsically phosphorylated on cysteine. Phos-tag analysis of cell lysates shows close to 50% of transiently expressed FLAG-PRL1, -2, and -3 are phosphorylated. The phosphorylated PRL bands are marked by an asterisk.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_5-B</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, Immunoblots of PRL1 expressed in HEK293 cells show phosphorylation requires the catalytic cysteine (C104) but not the adjacent cysteine (C49) in the active site.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_5-C</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C, Co-immunoprecipitation of Myc-PRL by FLAG-CNNMs shows only the unphosphorylated forms of PRL1 binds CNNM4.</text>
    </passage>
  </document>
  <document>
    <id>5283600 Figure_5-D</id>
    <infon key="sourcedata_document">2579</infon>
    <infon key="doi">10.15252/embr.201643393</infon>
    <infon key="pmc_id">5283600</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, Endogenous PRLs in HeLa cells are cysteine phosphorylated.</text>
    </passage>
  </document>
</collection>
